Accession Number : ADA346985
Title : Report of the NIH Panel to Define Principles of Therapy of HIV Infection and Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents. Vol. 47/No. RR-5.
Corporate Author : CENTERS FOR DISEASE CONTROL ATLANTA GA
Personal Author(s) : Feinberg, Mark B. ; Kaplan, Jonathan E.
Report Date : 25 APR 1998
Pagination or Media Count : 92
Abstract : Recent research advances have afforded substantially improved understanding of the biology of human immunodeficiency virus (HIV) infection and the pathogenesis of the acquired immunodeficiency syndrome (AIDS). With the advent of sensitive tools for monitoring HIV replication in in fected persons, the risk of disease progression and death can be assessed accurately and the efficacy of anti-HIV therapies can be determined directly. Furthermore, when used appropriate/v, combinations of newly available, potent antiviral therapies can effect prolonged suppression of detectable levels of HIV replication and circumvent the inherent tendency of HIV to generate drug-resistant viral variants. However, as antiretroviral viral therapy for HIV in fection has become increasingly effective, it has also become increasingly complex. Familiarity with recent research advances is needed to ensure that newly available therapies are used in ways that most effectively improve the health and prolong the fives of HIV infected persons. Th enable practitioners and HIV infected persons to best use rapidly accumulating new information about HIV disease pathogenesis and treatment, the Office of AIDS Research of the National Institutes of Health sponsored the NIH Panel to Define Principles of Therapy of HlV infection This Panel was asked to define essential scientific principles that should be used to guide the most effective use of antiretroviral therapies and viral load testing in clinical practice. Based on detailed consideration of the most current data, the Panel delineated eleven principles that address issues of fundamental importance for the treatment of HlV infection.
Descriptors : *CLINICAL MEDICINE , *ANTIVIRAL AGENTS , *HUMAN IMMUNODEFICIENCY VIRUSES , *PATHOGENESIS , *ACQUIRED IMMUNE DEFICIENCY SYNDROME , RISK , BIOLOGY , TOOLS , LOADS(FORCES) , ADOLESCENTS , TEST METHODS , DISEASES , SENSITIVITY , THERAPY , INFECTIOUS DISEASES , DEATH , ADULTS , DRUG TOLERANCE , RETROVIRUSES.
Subject Categories : MEDICINE AND MEDICAL RESEARCH
Distribution Statement : APPROVED FOR PUBLIC RELEASE